Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine whether endometrial receptivity markers obtained by endometrial sampling are effective in prediction of in vivo human embryo implantation.


Clinical Trial Description

Since the introduction of In vitro fertilization (IVF), substantial improvements have been developed in ovulation induction, oocyte retrieval, fertilization capability and embryonic development. However, the end point which is to improve implantation and pregnancy rates after transferring embryos, remains below physiological expectations. It has been estimated that clinical implantation in the human is efficient in no more than 30% of cases considering that only one embryo is present in natural cycles, which gives us a 30% implantation rate.

A frequent pitfall found in the literature is the consideration that implantation is the result of good embryonic quality. Although this is completely true, it is not the only truth because the maternal endometrium is at least of equal relevance. In ovum donation, the endometrial factor could also be improved by individualizing the implantation window in each patient. In this proposed research we will analyze suggested markers of endometrial receptivity in order to optimize human implantation in patients undergoing assisted reproductive technologies focusing on improving endometrial receptivity in IVF and ovum donation patients. ;


Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms


NCT number NCT00506480
Study type Interventional
Source Hadassah Medical Organization
Contact Ariel Revel, MD
Phone 97226777111
Email arielr2@hadassah.org.il
Status Not yet recruiting
Phase N/A
Start date August 2007

See also
  Status Clinical Trial Phase
Completed NCT02032797 - Optimal Length of Progesterone Supplementation Before the Transfer of Cryopreserved(Frozen)-Thawed Embryos in an Artificial Cycle With Exogenous Estrogen and Progesterone. Phase 4
Completed NCT04077970 - Intrauterine Flushing With Follicular Fluid Plus Granulosa Cells Phase 3
Terminated NCT00588250 - Clinical Trial of Novel Implantation Promoting Medium (EmbryoGlue) to Improve IVF Success Rates N/A
Completed NCT03485235 - Effect of Dilatation and Curettage on the Endometrial Receptivity N/A
Recruiting NCT02072291 - Nifedipine Treatment on Uterine Contractility in IVF Phase 2
Completed NCT02815371 - Laser Acupuncture Before and After Embryo Transfer Improves IVF Outcomes N/A
Completed NCT04855383 - Intramuscular Injection of Human Chorionic Gonadotropin in Frozen Embryo Transfer Cycles N/A
Recruiting NCT04721522 - The Impact of Endometrial Compaction on Assisted Reproductive Technology Outcome
Recruiting NCT04003337 - Selection of the Embryo to Transfer by Morphokinetics vs. Morphological Evaluation. N/A
Completed NCT02407730 - EFFects of Thrombophilia on the Outcomes of Assisted Reproduction Technologies
Completed NCT00635258 - Administration of GnRH Antagonist to Oocyte Donation Recipients N/A
Completed NCT03108157 - Endometrial Scratch Effect on Pregnancy Rates in Patients Undergoing Egg-donation IVF N/A
Terminated NCT04744844 - DNA Amplification in Blastocoel Fluid N/A
Active, not recruiting NCT05555121 - Rescue Progesterone Supplementation During Frozen Embryo Transfer Phase 2
Recruiting NCT04159649 - The Outcomes of ICSI Cycles With and Without Letrozole Phase 4
Completed NCT03128970 - Synchronizing Blastocyst in Frozen Embryo Transfer N/A